We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Lens Method Analyzes Tears for Early Disease Detection

By LabMedica International staff writers
Posted on 20 Dec 2024

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. More...

The presence of specific proteins in these biofluids can be a sign of health issues. Tears, in particular, are well-suited for detecting eye diseases such as glaucoma and macular degeneration, but they can also help identify systemic conditions like breast cancer and Alzheimer's disease. The challenge, however, is that collecting tears is difficult. Existing tear sampling methods can be uncomfortable, irritating to the eye, and typically yield reflex tears, which are less useful for disease detection. Now, researchers have developed an innovative technique using soft contact lenses to collect proteins from basal tears, offering a more efficient method for early disease detection.

While reflex tears are easily triggered by irritation, they are unlikely to contain the proteins needed for disease detection. These tears would dilute the indicator proteins that could point to a health issue. To avoid this, researchers at Brigham Young University (Provo, UT, USA) proposed a gentler approach: using soft contact lenses that naturally absorb proteins from the eye. Their tests showed that lenses made from the hydrogel material Etafilcon-A collected the highest protein levels without causing irritation.

In experiments, volunteers wore the contact lenses for just five minutes, and the lenses absorbed nearly the same range of proteins as traditional methods, but with significantly less discomfort. This new approach, as described in the study published in Clinical Proteomics, also allows patients to collect their own tears, removing the need for a trained optometrist. The research team is currently conducting further clinical trials to link specific tear proteins with diseases like macular degeneration and cancer. Their long-term goal is to make this method available in optometrists' and oncologists' offices, providing an easy and non-invasive way to detect early signs of various conditions.

“How many people could be helped if doctors could catch diseases before symptoms develop? With this new lens method, we could potentially screen for a range of health issues from analyzing tears,” said former grad student Robert Roden. “This project is very powerful in its scope. Any disease that your blood touches has the potential to show up in your tears. Hopefully this sampling can turn into a routine screening.”


New
Gold Member
Hybrid Pipette
SWITCH
Portable Electronic Pipette
Mini 96
ESR Analyzer
TEST1 2.0
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.